Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: Virology. 2010 Jun 15;405(1):31–40. doi: 10.1016/j.virol.2010.05.011

Fig. 5. Differential seroreactivity against HPVs early proteins.

Fig. 5

Fig. 5

Fig. 5

A. The differentially reactive E antigens comparing 280 subjects without lesions and 93 cervical cancer patients. B. The same antigens were plotted comparing 93 cancer patients with 50 HSIL patients. C. The same antigens were plotted comparing 280 subjects without Lesions with 50 HSIL patients. Multiple comparison corrected p-values less than 0.05 are considered significant (signal extending below the red horizontal line).